New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
10:22 EDTNUS, USNA, HLFNu Skin retreats despite stronger than expected pre-announcement
Shares of multi-level-marketing company Nu Skin (NUS) are falling, even though the company pre-announced stronger than expected fourth quarter results. WHAT'S NEW: Nu Skin estimated that its fourth quarter earnings per share would be $2-$2.02, versus analysts' consensus estimate of $1.91. The company estimated that its fourth quarter revenue would be $1.08 billion, which is slightly above expectations. Nu Skin stated that it was rescheduling its full earnings release and conference call until later this month, due to the company's ongoing review of its business in China and its desire to provide the most informed guidance possible. Nu Skin launched the review of its China business last month after Chinese regulators began probing the company. The Chinese government began an investigation into allegations, first raised by a Chinese newspaper, that Nu Skin operates an illegal pyramid scheme in the country. WHAT'S NOTABLE: Herbalife (HLF), like Nu Skin, also distributes personal care and nutritional products and operates in China. A Chinese media report last August suggested that Herbalife may be violating Chinese laws against pyramid schemes, The New York Post reported last month, adding that the government had not said that it was investigating Herbalife. PRICE ACTION: In early trading, Nu Skin dropped over 3% to $80.02 and Herbalife sank 2.7% to $67.14. A third company in the sector, USANA Health Sciences (USNA), was fractionally lower at $57.51.
News For NUS;HLF;USNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
12:58 EDTHLFHerbalife price target raised to $100 from $90 at Pivotal Research
Subscribe for More Information
August 25, 2015
08:00 EDTHLFTwitter wants to move Herbalife suit to California, NY Post reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use